000			01115nam a2200313 a 4500
005			20250914122313.0
008			020205s2002 xxua 001 0 eng b
020			_a0120726513 _cRM401.40
039		9	_a200408101117 _blailawati _c200405061238 _dzainol _c200207261555 _dafandi _c200206281025 _dafandi _y02-05-2002 _zlinda
060			_aQV269
090			_aQV269.A629515 2002 9HUKM[00099000762]
245	0	0	_aAnticancer drug development / _cedited by Bruce C. Baguley, David J. Kerr
260			_aSan Diego : _bAcademic Press, _c2002
300			_a397 p. : _bill. ; _c30 cm.
504			_aIncludes bibliographical references and index
650		2	_aAntineoplastic agents
650		2	_aDrug Design
650		2	_aDrug Evaluation, Preclinical
700	1		_aBaguley, Bruce C.
700	1		_aKerr, David J.
907			_a.b12971157 _b2019-11-12 _c2019-11-12
942			_c01 _n0 _kQV269.A629515 2002 9HUKM[00099000762]
914			_avtls000309038
991			_aJabatan Onkologi, HUKM
991			_aJabatan Farmasi
998			_ad _ah _b2002-05-02 _cm _da _feng _gxxu _y0 _z.b12971157
999			_c297541 _d297541